Dr. Dermott O’Callaghan is Head of Product Development at Stream Bio, and is responsible for the assay development used by Brightline’s Claritas platform. His scientific and technical expertise spans all stages of product/assay development, project management and drug discovery. Dermott leverages over 18 years of experience in the pharmaceutical industry with his extensive knowledge of in vitro molecular biology and its applications within the latest industry processes.
Using novel polymer fluorophores to study, detect and treat life-threatening diseases
With extremely bright fluorophores and a novel, highly sensitive reader, Brightline DX aims to bring lab-based levels of accuracy to the palm of your hand.